New Job Opportunity

Pack Health to upscale its headquarter facilities in Birmingham, adds 200 jobs

Leading patient engagement company Pack Health, a Quest Diagnostics company, announced plans to nearly double the space of its headquarter facilities in Birmingham and add at least 200 full-time employee positions based on economic development incentives from the state of Alabama in recognition of the public benefits accruing from the expansion of Pack Health’s landmark Birmingham facility. Through incentive support from the State of Alabama and Jefferson County, as well as local non-educational tax abatements, Pack Health will receive benefits projected to profoundly impact the economic state of Birmingham, Jefferson County and throughout Alabama. The investment, which includes recognition of Pack Health’s job creation from the state, county and city of Birmingham, is expected to generate up to $27 million in estimated overall economic impact over a 20-year period.

Pitt-Greensburg unveiled its new Life Sciences Building

The University of Pittsburgh at Greensburg celebrated the new year with the opening of its Life Sciences Building during a Jan. 12 ribbon-cutting in partnership with the Westmoreland County Chamber of Commerce. Construction on the two-story, 32,085-square-foot building began in September 2021 and was completed in December 2022. The $19.5 million structure is connected through a new chemistry wing to Smith Hall, which has served as the center for science-related education since its construction in the 1970s. The new Life Sciences Building, designed by Pittsburgh-based MCF Architecture, will house nursing, health science, biology, microbiology and chemistry labs, as well as faculty offices and shared study spaces. The new facility features seven laboratory spaces that science, nursing and nonscience disciplines will use: an anatomy and physiology lab, a general biology lab, a microbiology lab, an analytic chemistry lab, a general and advanced chemistry lab, an organic chemistry lab, and a chemistry prep space and research area for faculty. These will be coupled with a conference room, student study spaces and lobbies that lend themselves to study and conversation. Thanks to the generosity of the Elliott Group, study spaces and the lobbies on the first and second floors will bear its name. A third study space on the first floor is named the Dr. Guy M. and Nada L. Nicoletti Study Space. Two other study spaces will be named the Greensburg Foundation Family of Funds of The Community Foundation of Westmoreland County Study Spaces. “The laboratories in the new Life Sciences Building will greatly expand our teaching and research capabilities in the sciences,” said Gregerson. “The design of the Life Sciences Building provides students with numerous studying and gathering spaces on both floors that are comfortable and highly functional. We have also included outdoor seating that will be very attractive to students during the warm weather months. The design includes very large windows that provide an amazing amount of natural light for all rooms, creating a welcoming environment for all who work, study or visit the spaces.”

Upperton Pharma to build new facility in UK, creating 150 jobs by 2024

Upperton Pharma Solutions, a leading UK contract development and manufacturing organisation (CDMO), is delighted to announce that it has begun construction work for its new Development and GMP Manufacturing headquarters in Nottingham, UK. Working in close collaboration with its principal Design and Build contractor, T-SQUARED the team officially broke ground on the project on the 3rd of January and work has now started in earnest to deliver the new, 50,000 square foot facility which is expected to be fully operational by the end of 2023. The new site is situated at the recently opened Trent Gateway Business Park in Beeston and it will provide a significant expansion of the company’s capabilities in terms of capacity and scale of manufacture with the incorporation of ten new GMP manufacturing suites, Quality Control laboratories and dedicated Analytical and Formulation Development laboratories with pilot plant facilities. When fully operational it is expected to create in the region of 150 additional full-time jobs by the end of 2024.

DM Clinical Research Opens New Research Site

DM Clinical Research, a national network of clinical trial sites, has opened its first research location in the Boston metropolitan area and Massachusetts. The Houston, Texas-headquartered company also announced it will soon start enrolling patients in Moderna’s CMVictory Trial studying mRNA-1647, an investigational vaccine, to understand whether it can help the immune system protect against cytomegalovirus (CMV). Moderna was among the key biopharma and community partners that joined DM Clinical Research for a ribbon cutting celebration and tours of the 4,000-square-foot research site, which includes patient rooms, laboratory facilities, and vaccine storage and preparation rooms. The site address is 77 Pond Avenue, Suite 205C in Brookline. The Boston site enhances our ability to offer research sponsors access to a diverse patient footprint that already includes underserved communities in Chicago, Detroit, Houston and Philadelphia.” “DM Clinical Research is in a period of rapid growth with multiple new study sites added over the last two years in addition to the quadrupling of our staff to over 500 employees,” said DM Clinical Research Founder & CEO Mohammad Millwala. “We expect this transformational growth trajectory to continue for the foreseeable future, on the road to becoming the leading independent clinical research network in the nation.”

ScionHealth to acquire Cornerstone Healthcare, adds 3000 employees to ScionHealth’s network

ScionHealth reported the close of its previously announced acquisition of Cornerstone Healthcare Group (“Cornerstone”). The addition of Cornerstone’s talented caregivers and diversified portfolio of high-quality post-acute care facilities enhances ScionHealth’s position as a leading healthcare delivery network across 28 states and is an important step in executing the organization’s strategic plan for growth and innovation. The acquisition adds 15 specialty hospitals, eight senior living locations and approximately 3,000 talented employees to ScionHealth’s network to advance access to high-quality care, enhance innovation and improve the patient experience. The transaction expands ScionHealth’s national network of specialty and community-based hospitals and physician practices to deliver essential care solutions in local communities nationwide. “ScionHealth’s expansion, through the acquisition of Cornerstone, demonstrates our platform for growth and our priority in supporting exceptional patient and employee experiences in hospitals close to home,” said Rob Jay, chief executive officer of ScionHealth. “We are excited to add Cornerstone and its dedicated team members to ScionHealth, and eager to leverage best practices from both organizations to continue delivering compassionate, quality-focused care to patients across the country who place their trust in us.” “I am pleased to welcome the 3,000 talented caregivers from Cornerstone who share our vision to deliver best-in-class clinical expertise, healthcare solutions and innovation to ScionHealth’s specialty hospital family,” said Danny Brywczynski, president of ScionHealth’s Specialty Hospital Division. “Within our expanded specialty hospital portfolio, we will continue to deliver quality care and exceptional outcomes for the nation’s most medically complex patients.”

Berry supports growing healthcare market with new facility, will create 500 local jobs

US-based Berry Global Group, Inc. will begin product production at its new manufacturing facility and healthcare centre of excellence in Bengaluru as early as April 2023. Leveraging the company’s innovative research and development (R&D) solutions, this new Greenfield expansion project will improve regional and global access to advanced healthcare solutions; provide customers with necessary volume to support the forecasted growth for Asia’s domestic healthcare market; and boost India’s domestic economy by employing more than 500 new team members over the next eight years in Bengaluru, commonly referred to as India’s Silicon Valley. The new plant will improve global patient access to products for the Inhalation, Nasal, Ophthalmic, Dispensing, and Self-injection industries. And the new Berry Global Healthcare R&D Centre of Excellence will support the development of innovative solutions for existing and new applications to improve medicine administration and functionality, while helping customers’ meet ambitious sustainability goals. The R&D centre will be launching up to seven new products and projects in 2023 ranging from DPI Inhalers to plastics caps and closures. Included among these products will be Berry’s Pneumohaler, a lightweight, breath-actuated, multidose inhaler dose counter for the control and treatment of asthma and Chronic Obstructive Pulmonary Disease (COPD). Several new medical packaging products will be available for sampling with industrial prototypes in March 2023.

Seqens plans to double the number of scientists by 2026 at its new facility

Seqens Group, an integrated leader in the development and manufacture of active pharmaceutical ingredients (APIs) and intermediates, announced that it has opened Seqens Boston R&D Center, a state-of-the-art, 15,000 square-foot R&D center in Devens, Mass. Serving as one of the company’s global centers of excellence, the new facility will bring customers advanced capabilities for the discovery and development of new drugs and therapeutics. The $5 million investment ensures that the new facility will leverage the most advanced technologies, equipment and design, while adhering to the highest levels of quality, sustainability and safety. The new lab replaces an older, smaller R&D facility in Devens, and all current employees have moved to the new lab. Seqens plans to double the number of scientists there by 2026. The Seqens Boston R&D Center expands project flow, enhances quality and accelerates development of APIs and excipients, including lipids used for the manufacture of RNA vaccines for COVID. It will serve as the North American flagship for Seqens’ global R&D network – consisting of 10 R&D centers across Europe and North America and 300-plus scientists leveraging best-in-class technologies to support pharmaceutical customers from preclinical phases through to commercialization. The investment in Devens significantly strengthens the company’s U.S. operations – which also includes contract development and manufacturing facilities in Newburyport, Mass. – and signals Seqens’ commitment to broadening its reach into the U.S. The official opening comes just a year after SK Capital became a majority shareholder in the group by merging it with its portfolio company Wavelength Pharmaceuticals to create one of the largest, most diversified CDMOs in the world. “Everything starts with R&D. Transitioning our R&D center of excellence to the new Devens facility is an opportunity to continue our expansion into the U.S. market, within a state known as a vibrant academic hub, and support our customers with integrated R&D services that set new benchmarks for innovation, safety, sustainability and quality,” said Pierre Luzeau, president and CEO of Seqens Group.

Max Healthcare creates job opportunities at its new Super-Speciality Hospital

Max Healthcare Institute has announced plans to expand its existing tertiary care Max Super Speciality Hospital in Mohali. The construction of the new building that will house 170 beds has officially commenced with the ground-breaking ceremony held on 3 February. On completion of the project by end of Q3, 2024 the hospital bed capacity will go up to 400 beds from the existing 231 making it one of the largest private state-of-the-art medical institutions in the Tri-city. To be built with an investment of close to Rs 400 crore, this expansion will not only strengthen the existing healthcare infrastructure in the tri-city area and the state of Punjab but also create job opportunities at scale across clinical and non-clinical roles. The hospital currently employs close to 1,000 doctors, nurses and other full-time staff. For the past 11 years, Max Super Speciality Hospital has been addressing the rising healthcare needs of patient pool across Punjab as well as the neighbouring states of Haryana and Himachal Pradesh, Jammu & Kashmir. It records an average OPD consult footfall of over 10000 every month. The new building will house niche specialities including Liver Transplant, Bone Marrow, Transplant, Renal Transplant, Orthopaedics and Neurosciences.

Aracari Biosciences Expands to New Headquarters, Supports The Job Creation

Aracari Biosciences expands to new headquarters in Irvine, California after incubating for 3 years at University Lab Partners, the premier life science incubator in Irvine. “We are really excited about finding a new home in the Irvine community. We have outgrown the wonderful incubator space at University Lab Partners and now need a larger space to enable expansion of our services. We are experiencing a growing demand from pharmaceutical customers for testing novel drugs and immuno-oncology therapeutics and this move will allow us to expand our customer base,” said Dr. Wes Hatfield, Chairman and Co-founder of Aracari Biosciences. Aracari’s powerful next-generation tools are advancing discovery in immuno-oncology therapies and drug development. The 3D Vascularized Micro-Organ and Micro-Tumor platforms incorporate living, perfused human vasculature to deliver nutrients, drugs, and immune cells into the microenvironment of multiple tissue and tumor types, just as they are delivered in the human body. “We are very pleased to be staying in the Irvine community where we can tap into a diverse and exceptionally talented workforce,” shares Dr. Chris Hughes, the scientific Co-founder and Chief Scientific Officer of Aracari Biosciences. “This is exactly why University Lab Partners is so committed to developing the next generation of diverse life science innovators through our educational programming because as companies scale and grow, they need an activated local talent pipeline at-the-ready to support the job creation,” stated Karin Koch, Executive Director of University Lab Partners. “We say it takes a village, but it really takes an ecosystem supporting startups like Aracari Biosciences. It is always bittersweet to graduate companies, but we wouldn’t have a successful community without these alumni – our goal is to prepare them all to leave the nest.”

JustLogin and MyCLNQ Health collaborate to integrate digital healthcare services

JustLogin, the pioneer of cloud-based HR solutions in Southeast Asia, announced today the integration of JustLogin with MyCLNQ Health, a leading healthtech app based in Singapore. With the touch of a button on the JustLogin mobile app, JustLogin users can access a wide range of digital healthcare services from telemedicine, medical transport booking, to digital health screening via Single Sign-On (SSO). The collaboration makes JustLogin the first HR tech company in Singapore to integrate digital healthcare services into its platform, enabling Small and Medium Enterprises (SMEs) and their employees to benefit from MyCLNQ Health’s comprehensive, yet affordable ecosystem. Employees can take care of their healthcare needs with a convenient, one-stop solution fully integrated with their HR system, while SMEs can easily manage their health and wellness programmes to improve employee satisfaction. “Employee wellbeing is increasingly critical for SMEs, not only to ensure productivity among your talent but also to retain them over time. Through our collaboration with MyCLNQ Health, JustLogin is leading the industry and enabling the convergence of HR tech and healthtech for the benefit of our customers,” said Kwa Kim Chiong, Chief Executive Officer at JustLogin. “This integration will progressively extend across JustLogin’s entire suite of features, including Benefit, Leave and Payroll, to seamlessly address the administration of healthcare for employers and employees alike,” he added. “MyCLNQ Health is excited to partner with JustLogin to make healthcare more affordable and accessible. With a comprehensive family healthcare ecosystem readily available via JustLogin, employees are empowered to take care of themselves and be more engaged in getting personalised care and self-care decisions, while employers benefit from a happy, healthy workforce minus the hassle of sourcing and implementing complex programmes,” said Anwar Rafique, Chief Executive Officer at MyCLNQ Health. JustLogin customers are now able to use MyCLNQ Health as part of their subscription, chargeable on a per consultation basis. To support SMEs in their adoption of an integrated healthcare programme, JustLogin and MyCLNQ Health are extending an exclusive waiver of consultation fees for the first five consultations per company and 20% off any subsequent consultations in the first three months of MyCLNQ usage.